About Ergomed
Ergomed is a company based in Guildford (United Kingdom) founded in 1997 was acquired by Permira in September 2023. Ergomed has completed 9 acquisitions, including ADAMAS Consulting, Ergomed and GASD. Ergomed offers products and services including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting. Ergomed operates in a competitive market with competitors including hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
- Headquarter Guildford, United Kingdom
- Stage Public
- SectorsHealthcare
- Website ergomedplc.com
- Social LinkedIn Facebook YouTube
- Acquired by Permira (Sep 2023)
- Legal Name Ergomed Plc
- Latest Funding Round$5.53M (USD), Post-IPO
Feb 2018
- InvestorsPermira
& 1 more
- Investments & AcquisitionsADAMAS Consulting
& 8 more
- Acquired byPermira
(Sep 2023)
Products & Services of Ergomed
Ergomed offers a comprehensive portfolio of products and services, including Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Full-service CRO for oncology and rare diseases trials
End-to-end PV services from clinical development to post-marketing
Full range of GxP audits for drug development and surveillance
Apps and channels of Ergomed
its YouTube channel Ergomed Group has 568 subscribers and 30 videos.
Videos from Ergomed
The most watched videos on Ergomed's YouTube channel, Ergomed Group (568 subscribers). Click a video to play it here.
More on Ergomed Group.
Funding Insights of Ergomed
- Total Rounds 2
- Last Round Post-IPO — $5.53M
- Investors Count 1
All 2 funding rounds of Ergomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $5.53M | Post-IPO | – | – | – |
| Jun 2005 | – | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Ergomed
Ergomed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment solutions are provided by Catapult Ventures for growth. | – | catapult-ventures.com | Leicester, United Kingdom | |
Investments are made in technology, consumer, healthcare, and service sectors. | 1985 | permira.com | London, United Kingdom |
Investor details for Ergomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ergomed
48 people are tracked at Ergomed (36 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Bosko Vojkic | Senior Director Of Strategic Communications | Leadership |
Sohil Shah | Director | Leadership |
Yolanda Davis | Associate Project Director | Leadership |
Rada Gantly | Director Of Business Development Europe At Ergomed Group | Leadership |
Chris Henne | Director Of Business Development | Leadership |
Kailyn Bell | Executive Director Business Development | Leadership |
Miroslav Reljanovic | Executive Chairman & Interim CEO | Leadership |
Natalia Grassis | Executive Vice President Of Global Operations | Leadership |
Dylan Matzinger | Executive Vice President, Business Development | Leadership |
Barbara Skupień- Franczyk | Project Director | Leadership |
Clare Marie Burn | Director Of Business Development | Leadership |
Bernd Saynisch | Senior Director Business Development | Leadership |
Ines Medved Njiric | Vp, Proposals And Contracts | Leadership |
Thomas Portele | Vice President Project Management Office (vp Pmo) | Leadership |
Jonathan Curtain | Chief Financial Officer | Leadership |
Katrina Lewin | Director, HR Systems And People Analytics | Leadership |
Peter. Bradford | Chief Accountant | Leadership |
Sarah Adams | Director Talent Acquisition | Leadership |
Joanne Bletcher | Head Of Corporate Legal And Company Secretary | Leadership |
Alessandro di Ranno | Vice President Business Development Europe At Ergomed Group | Leadership |
28 more people are available in the full profile.
Complete people profiles for Ergomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ergomed
Ergomed has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ADAMAS Consulting, Ergomed and GASD.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmacovigilance and regulatory services for drugs and devices are provided. | panaceapharmaprojects.com | Douglas, United Kingdom | 2008 | Oct 2023 | •••• | |
Consulting and laboratory services are provided by ADAMAS Consulting. | adamasconsulting.com | Crowthorne, United Kingdom | 1997 | Feb 2022 | $34.66M | |
Full-service CRO operations are focused on oncology and complex trials. | medsource.com | Houston, United States | 1997 | Dec 2020 | •••• | |
Healthcare communications, medical affairs, and advisory services are provided. | ashfieldhealthcare.com | Washington, United States | 1997 | Jan 2020 | $10M | |
Pharmacovigilance and regulatory services are provided to pharmaceutical firms. | pharminvent.com | Prague, Czech Republic | 2010 | Nov 2016 | $5.1M | |
Statistics and data management services are provided for CROs. | gasd.de | Cologne, Germany | 1991 | Jun 2016 | •••• | |
Provider of clinical research and packaging services for pharmaceutical industry | oandp-cro.com | Cologne, Germany | 1991 | Jun 2016 | •••• | |
Developing new class of peptide based coagulant | haemostatix.com | Nottingham, United Kingdom | 2003 | May 2016 | $11.71M | |
Functional CRO offering pharmacovigilance services | primevigilance.com | Guildford, United Kingdom | 2008 | Jul 2014 | $15.3M |
Complete acquisition details for Ergomed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ergomed
14 dated milestones of Ergomed across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Ergomed is founded.
- Funding First funding round.
- Acquisition Acquires PrimeVigilance.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Haemostatix.
- Acquisition Acquires GASD.
- Acquisition Acquires oandp-cro.
- Acquisition Acquires PharmInvent.
- Funding Latest funding round, Post-IPO, of $5.5M.
- Acquisition Acquires Inizio.
- Acquisition Acquires Ergomed.
- Acquisition Acquires ADAMAS Consulting.
- Exit Acquired by Permira.
- Acquisition Acquires Panacea Pharma Projects.
Competitors of Ergomed
Ergomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as hVIVO, Chiltern International, ClinTec, Avillion and Celadon Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hvivo.com | 1998 | London, United Kingdom | – | 133 | Provider of cell based assays, field trial, and molecular services for biopharma sector | |
| chiltern.com | 1982 | Berkshire County, United States | – | – | Full service CRO with expertise in oncology related development services | |
| clintec.com | 1997 | Glasgow, United Kingdom | $12.51M | 36 | Clinical research services are provided globally to pharmaceutical industries. | |
| avillionllp.com | 2012 | London, United Kingdom | – | 2 | Clinical co-development services and financing for late-stage therapeutics are provided. | |
| celadonpharma.com | 2018 | London, United Kingdom | – | – | Provider of cannabis trial services | |
| simbecorion.com | 2014 | Slough, United Kingdom | – | – | Clinical trial management services are provided by this CRO. | |
| ttspharma.com | 2012 | Liverpool, United Kingdom | $13.94M | 6 | TTS Pharma is engaged in producing high-quality, safe Cannabinoid products. | |
| luto.co.uk | 2004 | Bradford, United Kingdom | – | – | Clinical trial studies and data management services are provided. |
Detailed competitors of Ergomed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ergomed
Complete news archive for Ergomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ergomed
10 companies that operate in the same segment as Ergomed (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 137 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ergomed
Ergomed was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Ergomed is headquartered in Guildford, United Kingdom.
Ergomed is a CRO operating in 50 countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.
Ergomed's top competitors include hVIVO, Chiltern International and Avillion.
Ergomed offers Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting.
Ergomed has made 9 acquisitions, including ADAMAS Consulting, Ergomed, and GASD.
Ergomed has 2 investors. Key investors include Permira, and Catapult Ventures.
Ergomed operates through Ergomed Plc.
Yes. Ergomed was acquired by Permira in September 2023.